Home Biosimilar Antibodies Microbiology RSV antibody Palivizumab (Anti-RSV-F) For research use only.
Not for use in humans.

Palivizumab (Anti-RSV-F)

Synonyms: MEDI 493

Palivizumab (Anti-RSV-F) is a humanized monoclonal antibody against the fusion protein (F protein) of human respiratory syncytial virus (RSV), with prophylactic application in respiratory syncytial virus infections. MW : 145.5 kD.

Palivizumab (Anti-RSV-F)

Purity & Quality Control

Batch: A236401 Purity: 99% Protein concentration: 8.37mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective RSV Inhibitors

Biological Activity

Description Palivizumab (Anti-RSV-F) is a humanized monoclonal antibody against the fusion protein (F protein) of human respiratory syncytial virus (RSV), with prophylactic application in respiratory syncytial virus infections. MW : 145.5 kD.

Product Details

CAS No. 188039-54-5
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Palivizumab (Anti-RSV-F) | Palivizumab (Anti-RSV-F) supplier | purchase Palivizumab (Anti-RSV-F) | Palivizumab (Anti-RSV-F) cost | Palivizumab (Anti-RSV-F) manufacturer | order Palivizumab (Anti-RSV-F) | Palivizumab (Anti-RSV-F) distributor